Once-daily oral sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris: Results from two identically designed, phase 3, randomized, double-blind clinical trials

Angela Moore, Lawrence J. Green, Suzanne Bruce, Neil Sadick, Eduardo Tschen, Philip Werschler, Fran E. Cook-Bolden, Sunil S. Dhawan, Douglass Forsha, Michael H. Gold, Scott Guenthner, Steven E. Kempers, Leon H. Kircik, Jennifer L. Parish, Marta I. Rendon, Phoebe Rich, Linda Stein-Gold, Stephen K. Tyring, Robert A. Weiss, Adnan NasirCarsten Schmitz, Terry I. Boodhoo, Alexandre Kaoukhov, David R. Berk

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Once-daily oral sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris: Results from two identically designed, phase 3, randomized, double-blind clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences